Inflammatory Bowel Disease (IBD), which includes Crohn’s disease and ulcerative colitis, affects millions of people worldwide and is known for its unpredictable nature, fluctuating symptoms, and highly individualized disease progression. Despite major advances in biologic therapies and small-molecule drugs, many patients still experience treatment failure, relapse, or persistent inflammation. A recent review by Stefan Schreiber, […]




